Pharmaceutical Economics and Policy
Springer Berlin (Verlag)
978-3-540-48261-1 (ISBN)
Jeff J. Guo, PhD, is Associate Professor of Pharmacoeconomics at the U. of Cincinnati (UC) College of Pharmacy, and Research Fellow of the Institute for the Study of Health at the UC Medical Center. He has worked as senior pharmacy systems engineer at Pharmacopeia in Rockville, MD; as research manager of pharmacoepidemiology & pharmacoeconomics at the Degge Group, in Arlington, VA; and as a government official at the China National Drug Administration and the China National Economic & Planning Commission. He is a founder of the Int. Society of Pharmacoeconomics and Outcomes Research (ISPOR) Asian Consortium Advisory Committee, and has experience with Ohio and Alabama state Medicaid drug utilization review and health policy research, US Pharmacopeia drug information, the national medication error report system MedMARx®, and contract research at major pharmaceutical companies. Christina M.L. Kelton, PhD, is Professor of Economics in the College of Business at the U. of Cincinnati (UC) and Research Associate at the Economics Center for Education & Research at UC. In her career as an academic economist, she held a post-doctoral appointment at the University of Wisconsin, and she subsequently taught at Case Western Reserve University, Wayne State University, the University of Minnesota, and the Pennsylvania State University. In her role as Research Associate for the Economics Center, she works on contract research projects primarily for regional clients, including the Greater Cincinnati Health Council and the Cincinnati Health Network.
Preface.- Introduction.- Pharmaceutical Industry Overview.- Pharmaceutical Research and Development.- Pharmaceutical Production.- Pharmaceutical Marketing and Distribution.- Pharmacy Benefit Management.- Patients, Physicians, Pharmacists, and Insurers.- Drug Utilization Patterns.- Demand and Utility Theory for Medications.- Elasticity of Demand for Medications.- Definition of Drug Prices.- Characteristics of Market Competition.- Brand-Name and Generic Drugs.- Analysis of Pricing Strategies.- New Drug Approval.- Drug Information.- Patent Policy.- Antitrust Law, Mergers and Acquisitions, and Price Discrimination.- Drug Utilization Review and Cost-Containment Strategies.- Dietary Supplements and Alternative Medicines.- Post-Marketing Drug Surveillance and Drug Safety.- Pharmacoeconomic Evaluations for Formulary Decisions.
| Erscheint lt. Verlag | 14.1.2016 |
|---|---|
| Zusatzinfo | Approx. 425 p. 50 illus. |
| Verlagsort | Berlin |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Schlagworte | Drug policy • Pharmacy • TUP |
| ISBN-10 | 3-540-48261-X / 354048261X |
| ISBN-13 | 978-3-540-48261-1 / 9783540482611 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
